Patient and family education for biotherapy in cancer treatment


Patient and family teaching highly relevant to biotherapy is a vital function of the oncology nurse. Nurses are likely involved in obtaining informed consent before initiation of treatment. Patients should be informed of the therapeutic benefits and perils associated with treatment in a fashion suitable for remarkable ability to understand.

Oncology nurses administering BRMs must clarify and reinforce information supplied by physicians at the appropriate interval. More information about BRMs might be ideal for patients and family members so that they are able to better understand the treatment plan.

An individualized teaching plan should be produced for all patients receiving BRMs. Patients self-administering BRMsrequire verbal and written instructions on preparation and administration techniques as well as self-care measures. Audiovisual aids can be a useful tool to strengthen teaching. Patients should be instructed concerning the proper storage and disposal of BRMs. Patients should be provided all of the necessary materials for self-administration.

Nurses must review all possible negative effects and symptom management with patients. Patients should be reassured that most toxicities are dose-, route-, or schedule-dependent and therefore are reversible once the treatment is discontinued. Nurses, in collaboration with physicians and patients, can establish interventions to reduce toxicities.

Control over negative effects and toxicities

Nurses administering BRMs should be certified in cardiopulmonary resuscitation. They ought to be in a position to assess for and manage the known and unexpected toxicities related to BRMs. Emergency equipment should be easily available because of the chance of an anaphylactic response. Nurses should conduct ongoing assessments of the patient's reaction to treatment. Patients administering BRMs in your own home may keep a diary to trace all toxicities and medicines taken for symptom management.

Many potential negative effects and toxicities are related to BRMs. They create a wide range of systemic toxicities. Along side it effects are generally dose-dependent and therefore are reversible once the treatment is discontinued. Two of the most common negative effects are flulike syndrome and fatigue. Flulike syndrome is seen as a fatigue, malaise, myalgia, arthralgia, headaches, and fever with chills.

Toxicities might be minimized by administering acetaminophen before and also at regular intervals after treatment. Patients experiencing fatigue report tiredness, exhaustion, weakness, insufficient energy, and wherewithal to concentrate. Patients should be instructed on conserving energy and planning rest periods during the day. Emphasis should be positioned on proper nutrition and hydration.

Legal Disclaimer

Our website is not responsible for the information contained by this article. Articleinput.com is a free articles resource thus practically any visitor can submit an article. However if you notice any copyrighted material, please contact us and we will remove the article(s) in discussion right away.

Note: This article was sent to us by: Kyle Jordan at 07262011

Related Articles

1. What chemotherapy is and how it is used in cancer treatment
Chemotherapy may be the utilization of cytotoxic agents to eliminate cancer cells. Chemotherapy goes back towards the 1500s, when chemical toxins were utilised systemically...

2. Cancer cell characteristics and how chemotherapy fights them
Every cell in the body includes a genetically programmed clock that directs the timing of their reproductive activity. Cancer is really a disease in that the cells neglect ...

3. Mitotic inhibitors and camptothecins in chemotherapy
Mitotic Inhibitors Mitotic inhibitors hinder the development of the mitotic spindle, causing metaphase arrest. They're primarily referred to as M-phase active, ho...

4. What is combination chemotherapy how does it fight cancer
Based on the Gompertzian type of tumor growth, tumors in their initial phases grow rapidly simply because they have a superior growth fraction. Eventually, because the tumo...

5. Monoclonal antibodies and their role in chemotherapy
Many tumor cells express substances on the surface that are unique to tumor cells. These substances might be absent or found in small quantities in normal cells, making tum...

6. Cytokines, interferons and toxicities in chemotherapy
Cytokines Cytokines are naturally sourced substances released from stimulated cells of the immune system. There is a big part in mediating the game of the immune ...

7. Interleukins in chemotherapy and cancer treatment
Interleukins are regulatory substances made by lymphocytes and monocytes. They bind to focus on cells to deliver messages between leukocytes. Interleukins demonstrate an ar...

8. Preventing chemotherapy errors for maximum patient safety
The chemotherapy administration process provides many opportunities for a number of medical professionals to make mistakes. The mistake may occur anywhere in the chemothera...

9. Routes of administration for chemotherapy in cancer patients
Following pretreatment assessment the RN may administer the chemotherapy. As advances in chemotherapy occur, the routes of administration still evolve. The option of drug r...

10. Minimizing contact with chemotherapeutic agents
Because of the healthcare personnel who handles antineoplastic agents, questions have arisen about possible long-term perils associated with contact with these drugs. The t...